Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -73.92% is 46% above its 5-year average of -137.83%, near the high end of its 5-year range (-297.28%–-57.62%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.78% below its 12-month average of -63.84%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -73.92%.
RETURN ON INVESTED CAPITAL (ROIC)
-73.92%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-63.84%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-149.18%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-137.83%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-191.44%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-15.78%
CURRENT VS 3Y AVG
+50.45%
CURRENT VS 5Y AVG
+46.37%
CURRENT VS 10Y AVG
+61.39%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-107.38%
vs the sector median at left
PAVmed Inc.
Market Cap
$16.72M
Return on Invested Capital (ROIC)
-73.92%
TTM Avg
-63.84%
3Y Avg
-149.18%
5Y Avg
-137.83%
Market Cap
$16.74M
Return on Invested Capital (ROIC)
-125.44%
TTM Avg
-125.44%
3Y Avg
-1118.57%
5Y Avg
-719.84%
Market Cap
$16.64M
Return on Invested Capital (ROIC)
-85.72%
TTM Avg
-120.02%
3Y Avg
-101.35%
5Y Avg
-83.66%
Market Cap
$16.82M
Return on Invested Capital (ROIC)
-79.20%
TTM Avg
-52.44%
3Y Avg
-44.71%
5Y Avg
-48.21%
Market Cap
$16.84M
Return on Invested Capital (ROIC)
-88.07%
TTM Avg
-68.32%
3Y Avg
-78.67%
5Y Avg
-76.64%
Market Cap
$16.52M
Return on Invested Capital (ROIC)
-279.48%
TTM Avg
-96.52%
3Y Avg
-105.30%
5Y Avg
-89.17%
Market Cap
$17.31M
Return on Invested Capital (ROIC)
-57.74%
TTM Avg
-38.37%
3Y Avg
-49.64%
5Y Avg
-45.59%
Market Cap
$17.39M
Return on Invested Capital (ROIC)
-46.69%
TTM Avg
-40.71%
3Y Avg
-34.73%
5Y Avg
-24.39%
Market Cap
$15.78M
Return on Invested Capital (ROIC)
-273.70%
TTM Avg
-707.06%
3Y Avg
-535.27%
5Y Avg
-358.40%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PAVmed Inc. (PAVM) | $16.72M | -73.92% | -63.84% | -149.18% | -137.83% |
| Palatin Technologies, Inc. (PTN)vs › | $16.74M | -125.44% | -125.44% | -1118.57% | -719.84% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.64M | -85.72% | -120.02% | -101.35% | -83.66% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.82M | -79.20% | -52.44% | -44.71% | -48.21% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.84M | -88.07% | -68.32% | -78.67% | -76.64% |
| Dyadic International, Inc. (DYAI)vs › | $16.52M | -279.48% | -96.52% | -105.30% | -89.17% |
| Lipocine Inc. (LPCN)vs › | $17.31M | -57.74% | -38.37% | -49.64% | -45.59% |
| Cosmos Health Inc. (COSM)vs › | $17.39M | -46.69% | -40.71% | -34.73% | -24.39% |
| BioCardia, Inc. (BCDA)vs › | $15.78M | -273.70% | -707.06% | -535.27% | -358.40% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.68M | -41.81% | -159.62% | -298.97% | -203.41% |
ROIC
-73.9%
ROE
-34.5%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -73.92% |
| 2026-03-31 | -57.62% |
| 2025-12-31 | -62.18% |
| 2025-09-30 | -58.51% |
| 2025-06-30 | -67.00% |
| 2025-03-31 | -72.31% |
| 2024-12-31 | -182.96% |
| 2024-09-30 | -222.34% |
| 2024-06-30 | -198.62% |
| 2024-03-31 | -224.74% |
| 2023-12-31 | -297.28% |
| 2023-09-30 | -236.93% |
| 2023-06-30 | -184.91% |
| 2023-03-31 | -155.58% |
| 2022-12-31 | -196.18% |
| 2022-09-30 | -130.45% |
| 2022-06-30 | -104.62% |
| 2022-03-31 | -98.67% |
| 2021-12-31 | -68.49% |
| 2021-09-30 | -119.97% |
| 2021-06-30 | -81.19% |
| 2021-03-31 | -54.15% |
| 2020-12-31 | -161.19% |
| 2020-09-30 | -353.95% |
| 2020-06-30 | -489.84% |
| 2020-03-31 | -369.97% |
| 2019-12-31 | -408.32% |
| 2019-09-30 | -630.46% |
| 2019-06-30 | -251.35% |
| 2019-03-31 | -455.46% |
| 2018-12-31 | -194.65% |
| 2018-09-30 | -134.02% |
| 2018-06-30 | -92.09% |
| 2018-03-31 | -313.13% |
| 2016-09-30 | -408.42% |
| 2016-06-30 | -119.34% |
| 2015-12-31 | -280.26% |
